Role of epithelial cell intracellular trafficking in the innate immune response to adenovirus infection
上皮细胞胞内运输在腺病毒感染先天免疫反应中的作用
基本信息
- 批准号:10209611
- 负责人:
- 金额:$ 36.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-10 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAddressAdenovirus InfectionsAdenovirus VectorAdenovirusesAdultAntiviral TherapyApicalAttenuatedAutophagocytosisBackBiologicalBiological ProcessCalmodulinCell AdhesionCell PolarityCell membraneCell modelCellsCellular StressCellular Stress ResponseChronic lung diseaseClathrin AdaptorsClinicalCyclic AMP-Dependent Protein KinasesCytoskeletonDataDevelopmentDiseaseDockingEndoplasmic ReticulumEndosomesEpidermal Growth Factor ReceptorEpithelialEpithelial CellsExhibitsExposure toFailureFutureGAB1 geneGenesGenetic TranscriptionGoalsHumanImmuneImmune responseImmune signalingIndividualInfectious AgentInflammatoryInnate Immune ResponseInnate Immune SystemInvadedKnowledgeLeadLigandsLinkLung diseasesLung infectionsMalignant NeoplasmsMammalian CellMasksMedicalMembraneMembrane ProteinsModelingMolecularMolecular ConformationMultivesicular BodyNatural ImmunityOncolyticPathogenesisPathologicPathway interactionsPhysiologicalPlayProcessProtein SortingsProteinsReceptor SignalingRecombinantsRecyclingResearchRespiratory SystemRespiratory Tract InfectionsRoleSerotypingSignal PathwaySignal TransductionSorting - Cell MovementStimulusStressStructure of respiratory epitheliumSurfaceTNF geneTestingTherapeuticTherapeutic InterventionTissuesTransplant RecipientsVirusapical membranebasebasolateral membranebeta cateninbiological adaptation to stresscytokinedesignezringene productgene therapy clinical trialhuman diseaseinnate immune functioninsightnew therapeutic targetnovelnovel therapeuticspathogenprotein activationpublic health relevancereceptorreceptor expressionreceptor functionrelease of sequestered calcium ion into cytoplasmrespiratoryresponsesrc-Family Kinasestraffickingtranscytosis
项目摘要
ABSTRACT
The apical surface of polarized epithelium constitutes one of the first points of contact between the host and
pathogens such as human adenoviruses (HAdVs) that invade the lumen of the respiratory tract. In recent
years, it has become clear that respiratory epithelial cells not only serve as functional and physical barriers, but
actively contribute to the innate immune system providing initial protection against external pathogens. The
EGF receptor (EGFR), which typically exhibits basolateral polarity, has emerged as a key player in the innate
immunity of respiratory epithelium to a variety of infectious and noninfectious noxious stimuli. In contrast to the
canonical ligand-stimulated EGFR pathway, a number of cellular stresses including HAdV infection (our
studies) trigger an alternative mode of EGFR trafficking associated with sustained EGFR activity in non-
degradative endosomes. However, molecular mechanisms regulating this pathway remain poorly understood.
In addition, despite significant progress in understanding the pathological and therapeutic stresses that activate
it, relatively little is known about EGFR function in the context of cellular stress. We have recently found that
stress-induced EGFR signaling is involved in innate immune responses triggered by HAdV cell entry, as well
as following exposure to the pro-inflammatory cytokine TNF-α, in respiratory epithelial cells. Moreover, HAdV
encodes an early gene product that suppresses this pathway by promoting EGFR degradation, and which
could provide new insights to potential targets for future anti-viral therapies. Interestingly, our preliminary
studies have revealed that EGFR stress responses were tightly regulated by epithelial cell polarity, with robust
stress-induced EGFR responses only observed when receptors were mistargeted to apical membranes. In
addition, HAdV co-opted cellular pathways contributing to innate immune signaling by enabling dynamic EGFR
membrane remodeling associated with enhanced stress-induced EGFR signaling from apical membranes.
The newly described EGFR innate immune system is likely to have a central role in protecting the lung from
infection with HAdVs and perhaps other pathogens. Conversely, failure to curb this signaling network may lead
to tissue damage, respiratory compromise, and potentially systemic HAdV infections. Our research plan will
identify novel mechanisms regulating dynamic EGFR membrane remodeling in polarized epithelial cells (Aim
1), and stress-induced EGFR innate immune signaling from endosomes (Aim 2); and analyze EGFR innate
immune signaling pathways that are activated as a consequence of HAdV infection in primary human
respiratory epithelial cells and new physiological cells models with enhanced apical EGFR expression (Aim 3).
Although our studies will be carried out in the context of HAdVs, successful completion of this project will have
a broad impact on a variety of respiratory conditions in need of new therapies.
抽象的
极化上皮的顶面构成宿主和宿主之间的第一个接触点之一。
侵入呼吸道内腔的病原体,例如人类腺病毒 (HAdV)。近来
多年来,人们已经清楚呼吸道上皮细胞不仅充当功能和物理屏障,而且
积极促进先天免疫系统,提供针对外部病原体的初步保护。这
EGF 受体 (EGFR) 通常表现出基底外侧极性,已成为先天性免疫调节的关键参与者。
呼吸道上皮对各种感染性和非感染性有害刺激的免疫力。相比之下
经典配体刺激的 EGFR 通路、许多细胞应激,包括 HAdV 感染(我们的
研究)触发了一种与非EGFR持续活性相关的EGFR运输的替代模式
降解内体。然而,调节该途径的分子机制仍然知之甚少。
此外,尽管在理解激活的病理和治疗应激方面取得了重大进展
然而,对于细胞应激背景下 EGFR 的功能知之甚少。我们最近发现
应激诱导的 EGFR 信号传导也参与 HAdV 细胞进入触发的先天免疫反应
呼吸道上皮细胞暴露于促炎细胞因子 TNF-α 后。此外,HAdV
编码一种早期基因产物,通过促进 EGFR 降解来抑制该途径,并且
可以为未来抗病毒治疗的潜在靶点提供新的见解。有趣的是,我们的初步
研究表明,EGFR 应激反应受到上皮细胞极性的严格调节,具有强大的
仅当受体错误定位于顶膜时,才会观察到应激诱导的 EGFR 反应。在
此外,HAdV 通过启用动态 EGFR 来选择细胞途径,从而促进先天免疫信号传导
膜重塑与顶膜应激诱导的 EGFR 信号传导增强相关。
新描述的 EGFR 先天免疫系统可能在保护肺部免受
感染 HAdV 或其他病原体。相反,如果未能遏制该信号网络,可能会导致
组织损伤、呼吸系统损害和潜在的全身性 HAdV 感染。我们的研究计划将
确定调节极化上皮细胞动态 EGFR 膜重塑的新机制(目标
1) 以及应激诱导的内体 EGFR 先天免疫信号传导(目标 2);并分析 EGFR 先天性
原代人类感染 HAdV 后被激活的免疫信号通路
呼吸道上皮细胞和具有增强的顶端 EGFR 表达的新生理细胞模型(目标 3)。
虽然我们的研究将在 HAdV 的背景下进行,但该项目的成功完成将
对需要新疗法的各种呼吸系统疾病产生广泛影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CATHLEEN R CARLIN其他文献
CATHLEEN R CARLIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CATHLEEN R CARLIN', 18)}}的其他基金
Role of epithelial cell intracellular trafficking in the innate immune response to adenovirus infection
上皮细胞胞内运输在腺病毒感染先天免疫反应中的作用
- 批准号:
10549310 - 财政年份:2021
- 资助金额:
$ 36.83万 - 项目类别:
Role of epithelial cell intracellular trafficking in the innate immune response to adenovirus infection
上皮细胞胞内运输在腺病毒感染先天免疫反应中的作用
- 批准号:
10368996 - 财政年份:2021
- 资助金额:
$ 36.83万 - 项目类别:
Modulation of Rab7-Dependent Degradative Pathways by Novel Adenovirus Protein
新型腺病毒蛋白对 Rab7 依赖性降解途径的调节
- 批准号:
7995957 - 财政年份:2008
- 资助金额:
$ 36.83万 - 项目类别:
Modulation of Rab7-Dependent Degradative Pathways by Novel Adenovirus Protein
新型腺病毒蛋白对 Rab7 依赖性降解途径的调节
- 批准号:
8197511 - 财政年份:2008
- 资助金额:
$ 36.83万 - 项目类别:
Modulation of Rab7-Dependent Degradative Pathways by Novel Adenovirus Protein
新型腺病毒蛋白对 Rab7 依赖性降解途径的调节
- 批准号:
7741208 - 财政年份:2008
- 资助金额:
$ 36.83万 - 项目类别:
Control of ErbB Receptor Sorting in Endosomes
内体中 ErbB 受体分选的控制
- 批准号:
6654464 - 财政年份:2002
- 资助金额:
$ 36.83万 - 项目类别:
Control of ErbB Receptor Sorting in Endosomes
内体中 ErbB 受体分选的控制
- 批准号:
6544872 - 财政年份:2002
- 资助金额:
$ 36.83万 - 项目类别:
Control of ErbB Receptor Sorting in Endosomes
内体中 ErbB 受体分选的控制
- 批准号:
6945125 - 财政年份:2002
- 资助金额:
$ 36.83万 - 项目类别:
MECHANISMS OF ABERRANT EGF RECEPTOR SORTING IN POLYCYSTIC KIDNEY DISEASE
多囊肾疾病中异常 EGF 受体分选的机制
- 批准号:
6651773 - 财政年份:2002
- 资助金额:
$ 36.83万 - 项目类别:
Control of ErbB Receptor Sorting in Endosomes
内体中 ErbB 受体分选的控制
- 批准号:
6794606 - 财政年份:2002
- 资助金额:
$ 36.83万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 36.83万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 36.83万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 36.83万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 36.83万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 36.83万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 36.83万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 36.83万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 36.83万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 36.83万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 36.83万 - 项目类别:
Research Grant














{{item.name}}会员




